Login / Signup

Patient-Reported Experiences in Voxelotor-Treated Children and Adults with Sickle Cell Disease: A Semistructured Interview Study.

Clark BrownModupe IdowuRichard DrachtmanAnne BeaubrunIrene AgodoaAndy NguyenKelly LipmanOlga MoshkovichRyan MurphyM Alex BellengerWally R Smith
Published in: BioMed research international (2023)
This study provides patient and caregiver perspectives on the symptomatic benefits of voxelotor treatment. These findings not only highlight the benefits of voxelotor treatment in improving symptoms and increasing health-related quality of life across the entire SCD population but also can inform further research on SCD-specific patient-reported outcomes.
Keyphrases
  • patient reported outcomes
  • mental health
  • young adults